Jury Awards Accutane Victim $10.5 Million Verdict
April 23, 2008
A jury has awarded $10.5 million to a 24 year old Utah woman who claims Accutane, a drug used to treat severe acne, caused her to develop ulcerative colitis. Out of the approximately 425 existing accutane lawsuits brought by patients who allege Accutane caused them to develop some form of inflammatory bowel disease, this was the third inflammatory bowel disease accutane lawsuit to go to trial. All three trials have resulted in multi-million dollar judgments against Accutane’s maker, Hoffmann-La Roche Inc (Roche).
Accutane and Inflamatory Bowel Disease
Accutane, which was approved by the FDA in 1982, has been the subject of controversy for years. In addition to inflammatory bowel disease, Accutane has been linked to various other serious side effects. To begin with, Accutane attracted negative publicity in the late 1980s for causing severe birth defects. Accutane has also been known to cause psychiatric problems, and has been linked to 266 cases of suicide in the United States. Additionally, Accutane has been associated with liver, kidney, central nervous system, pancreas, cardiovascular, musculoskeletal, and auto-immune system problems.
Accutane IBD Victim Profile
According to the Wall Street Journal, Kamie Kendall started taking Accutane at age 12. At the age of 14, Kamie was diagnosed with ulcerative colitis, and in 2006 she had her colon removed. Now, Kamie suffers from severe, chronic diarrhea. The jury awarded Kamie $10.5 million in compensatory damages plus $78,500 for medical expenses.
Past Accutane Jury Verdicts
Kendall is the third Accutane plaintiff suffering from inflammatory bowel disease to win a jury verdict against Roche. In May 2007, another New Jersey jury awarded $2.62 million to an Accutane patient who had to have his colon and most of his rectum removed. In October 2007, A Florida jury found that Roche failed to adequately warn an Accutane patient about inflammatory bowel disease and awarded that patient $7 million.
Roche Intends to Appeal Jury Verdicts
Roche plans to appeal the verdicts against it and insists that the link between Accutane and inflammatory bowel disease remains unproven. Additionally, the company has stated that “the Accutane labeling has contained a warning about IBD for more than 20 years.”
Accutane IBD Injury Help
If you or a loved one has IBD while taking Accutane or otherwise injured, please contact us today as you may be entitled to compensation for your injuries.